Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Raw Materials (2022 - 2025)

Historic Raw Materials for Ekso Bionics Holdings (EKSO) over the last 4 years, with Q3 2025 value amounting to $3.8 million.

  • Ekso Bionics Holdings' Raw Materials fell 411.03% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year decrease of 411.03%. This contributed to the annual value of $3.6 million for FY2024, which is 1738.02% down from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Raw Materials stood at $3.8 million, which was down 411.03% from $4.0 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Raw Materials high stood at $4.3 million for Q4 2023, and its period low was $3.6 million during Q4 2024.
  • Over the past 4 years, Ekso Bionics Holdings' median Raw Materials value was $4.0 million (recorded in 2024), while the average stood at $4.0 million.
  • Its Raw Materials has fluctuated over the past 5 years, first skyrocketed by 1201.46% in 2023, then plummeted by 1738.02% in 2024.
  • Quarter analysis of 4 years shows Ekso Bionics Holdings' Raw Materials stood at $3.8 million in 2022, then rose by 12.01% to $4.3 million in 2023, then dropped by 17.38% to $3.6 million in 2024, then increased by 5.77% to $3.8 million in 2025.
  • Its Raw Materials was $3.8 million in Q3 2025, compared to $4.0 million in Q2 2025 and $3.7 million in Q1 2025.